Sickle cell disease (SCD) altered CD8+ T-cell chromatin architecture, triggering ferroptosis and weakening antitumor immunity ...

The mechanisms governing immune-related adverse events resulting from checkpoint inhibition therapy for cancer remain a ...

The future is bright for prostate cancer research. It's glowing, in fact, thanks to new tools that combine the eye-catching ...

Researchers say, “It turns out SSRIs don’t just make our brains happier; they also make our T cells happier—even while ...

How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after infection clears.

CHIKV can trigger long-term joint pain that mimics autoimmune diseases like rheumatoid arthritis, potentially due to ...

Jerusalem Jerusalem, May 28: In a significant medical breakthrough, researchers from Israel’s Weizmann Institute of Science (WIS) have uncovered the biological secret behind one of the body’s most ...

The antibody PLT012 targets the fat transporter CD36 to restore immune responses in tumors, offering a new and promising ...

Spatial transcriptomics may transform prostate cancer research by mapping immune cell localization and gene expression in ...